Aging and endothelin: Determinants of disease
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Since the beginning of the 20th century human life expectancy has doubled to more than 80 years, and growth and aging of the world population now represent major challenges for healthcare providers, political decision makers, and societies. Cellular senescence is associated with a general, pro-inflammatory state, which represents the common denominator between aging and chronic diseases and their progression. Approaches to interfere with these changes and to allow healthy aging involve modulation of the cellular activity of modifiable molecular mediators (MMMs), such as signaling molecules and growth factors. ET-1 - the biologically predominant member of the endothelin peptide family - is an endothelial cell-derived peptide with a wide variety of developmental and physiological functions, which include embryogenesis, nociception, and natriuresis. In addition, ET-1 is a cytokine-like, multifunctional peptide with pro-inflammatory, mitogenic, and vasoconstrictor properties. If produced in excess amounts ET-1 promotes disease - mainly via activation of its ETA receptor. Because of its multiple disease-promoting functions ET-1 represents an ideal target MMM. Preclinical studies targeting either activity or production of ET-1 - utilizing ERAs, ARBs, or ACEIs, respectively - have demonstrated that partial regression of aging-associated changes in vasculature and kidney is possible. In this article I will review the molecular regulation of ET-1 and its role in the physiology of vascular homeostasis, aging, and cellular senescence. The clinical implications of activators of ET-1 overproduction, modalities for delaying or reversing aging-related cellular changes, as well as interventions to promote healthy aging and early disease prevention - particularly physical activity - are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thompson, P. D., Buchner, D., Piña, I. L., Balady, G. J., Williams, M. A., Marcus, B. H., Berra, K., Blair, S. N., Costa, F., Franklin, B., et al. (2003) · Circulation · doi:10.1161/01.cir.0000075572.40158.77 · Cited by 2,132 · cited 2×
“Please cite this article as: Barton M, Aging and endothelin: Determinants actively promoting its use (Exercise Medicine Initiative, 2014; Haskell et al., 2007; Swedish National Institute of Public Health, 2010; Thompson et al., 2003; Zoghbi et al., 2014), including different recommendations by theWorldHealthOrganizati…”
BackgroundMethodSuppression of Aging in Mice by the Hormone Klotho
Kurosu, H., Yamamoto, M., Clark, J. D., Pastor, J. V., Nandi, A., Gurnani, P., McGuinness, O. P., Chikuda, H., Yamaguchi, M., Kawaguchi, H., et al. (2005) · Science · doi:10.1126/science.1112766 · Cited by 1,935
Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction
Guzik, T. J., Hoch, N. E., Brown, K. A., McCann, L. A., Rahman, A., Dikalov, S., Goronzy, J., Weyand, C., & Harrison, D. G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070657 · Cited by 1,736 · cited 2×
“As discussed above, vascular inflammation has been identified in arterial hypertension (Guzik et al., 2007; Harrison et al., 2012; Schiffrin, 2014) as well as in aging (Bural et al., 2013; Ferrucci et al., 2005; Franceschi et al., 2000; Wang et al., 2007).”
BackgroundReversal of human cellular senescence: roles of the p53 and p16 pathways
Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg417 · Cited by 1,457
Programmed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428
Molecular inflammation: Underpinnings of aging and age-related diseases
Chung, H. Y., Cesari, M., Anton, S., Marzetti, E., Giovannini, S., Seo, A. Y., Carter, C., Yu, B. P., & Leeuwenburgh, C. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2008.07.002 · Cited by 1,203
Senescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186
Proinflammatory Cytokines, Aging, and Age-Related Diseases
Michaud, M., Balardy, L., Moulis, G., Gaudin, C., Peyrot, C., Vellas, B., Cesari, M., & Nourhashemi, F. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.05.009 · Cited by 1,094 · cited 1×
“Indeed, aging is associated with specific changes in innate and adaptive immunity, promoting a pro-inflammatory milieu (Bruunsgaard et al., 2003; Chung et al., 2009; Michaud et al., 2013).”
BackgroundThe origins of age-related proinflammatory state
Ferrucci, L., Corsi, A., Lauretani, F., Bandinelli, S., Bartali, B., Taub, D. D., Guralnik, J. M., & Longo, D. L. (2005) · Blood · doi:10.1182/blood-2004-07-2599 · Cited by 908
Immunosenescence: emerging challenges for an ageing population
Aw, D., Silva, A. B., & Palmer, D. B. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02555.x · Cited by 880 · cited 1×
“Immunosenescence has been implicated in the clinical course of viral or bacterial infections in the elderly who more often become critically ill than do middle-aged adults (Aw et al., 2007; Girard and Ely, 2007).”
BackgroundGruver, A., Hudson, L., & Sempowski, G. (2007) · The Journal of Pathology · doi:10.1002/path.2104 · Cited by 834 · cited 2×
“The increased age-related risk may be partly related to changes in immunity and the overall immune defense in the elderly which have been linked to the increased susceptibility for disease (including an increased incidence of cancer) and infection (Franceschi et al., 2000; Gruver et al., 2007; Thoman and Weigle, 1989)…”
BackgroundCauses, consequences, and reversal of immune system aging
Montecino-Rodriguez, E., Berent-Maoz, B., & Dorshkind, K. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64096 · Cited by 793 · cited 2×
“…but in fact accessible to numerous (therapeutic) interventions (Ma et al., 2000; Newgard and Sharpless, 2013; Adamczak et al., 2004, 2003; Benigni et al., 2009; Dorshkind and Swain, 2009; Laufs et al., 2004; Montecino-Rodriguez et al., 2013; Ortmann et al., 2004; Werner et al., 2009, 2008).”
BackgroundArterial Aging: Is It an Immutable Cardiovascular Risk Factor?
Najjar, S. S., Scuteri, A., & Lakatta, E. G. (2005) · Hypertension · doi:10.1161/01.hyp.0000177474.06749.98 · Cited by 640
Physiology of cardiovascular aging
Folkow, B., & Svanborg, A. (1993) · Physiological Reviews · doi:10.1152/physrev.1993.73.4.725 · Cited by 391
Physical Exercise Prevents Cellular Senescence in Circulating Leukocytes and in the Vessel Wall
Werner, C., Fürster, T., Widmann, T., Pöss, J., Roggia, C., Hanhoun, M., Scharhag, J., Büchner, N., Meyer, T., Kindermann, W., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.861005 · Cited by 380 · cited 2×
“…but in fact accessible to numerous (therapeutic) interventions (Ma et al., 2000; Newgard and Sharpless, 2013; Adamczak et al., 2004, 2003; Benigni et al., 2009; Dorshkind and Swain, 2009; Laufs et al., 2004; Montecino-Rodriguez et al., 2013; Ortmann et al., 2004; Werner et al., 2009, 2008).”
BackgroundHypertension in overweight and obese primary care patients is highly prevalent and poorly controlled
BRAMLAGE, P., PITTROW, D., WITTCHEN, H., KIRCH, W., BOEHLER, S., LEHNERT, H., HOEFLER, M., UNGER, T., & SHARMA, A. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.05.017 · Cited by 328
Elevated levels of tumor necrosis factor alpha and mortality in centenarians
Bruunsgaard, H., Andersen-Ranberg, K., Hjelmborg, J. V. B., Pedersen, B. K., & Jeune, B. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00329-2 · Cited by 325
Mercken, E. M., Crosby, S. D., Lamming, D. W., JeBailey, L., Krzysik‐Walker, S., Villareal, D. T., Capri, M., Franceschi, C., Zhang, Y., Becker, K., et al. (2013) · Aging Cell · doi:10.1111/acel.12088 · Cited by 261 · cited 1×
“…over the past decade provide compelling evidence that aging-associated cellular changes may not be all inexorable, but that aging– similar to arterial hypertension and obesity – can be considered a modifiable risk factor (Beauséjour et al., 2003; Mercken et al., 2013a;Mercken et al., 2013b).”
BackgroundWerner, C., Hanhoun, M., Widmann, T., Kazakov, A., Semenov, A., Pöss, J., Bauersachs, J., Thum, T., Pfreundschuh, M., Müller, P., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.034 · Cited by 239 · cited 2×
“…but in fact accessible to numerous (therapeutic) interventions (Ma et al., 2000; Newgard and Sharpless, 2013; Adamczak et al., 2004, 2003; Benigni et al., 2009; Dorshkind and Swain, 2009; Laufs et al., 2004; Montecino-Rodriguez et al., 2013; Ortmann et al., 2004; Werner et al., 2009, 2008).”
BackgroundThe role of inflammation in age-related disease
Howcroft, T. K., Campisi, J., Louis, G. B., Smith, M. T., Wise, B., Wyss-Coray, T., Augustine, A. D., McElhaney, J. E., Kohanski, R., & Sierra, F. (2013) · Aging · doi:10.18632/aging.100531 · Cited by 239
Aerobic fitness is associated with lower proportions of senescent blood T-cells in man
Spielmann, G., McFarlin, B. K., O’Connor, D. P., Smith, P. J. W., Pircher, H., & Simpson, R. J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.07.226 · Cited by 180
Wang, C.-Y., Kim, H.-H., Hiroi, Y., Sawada, N., Salomone, S., Benjamin, L. E., Walsh, K., Moskowitz, M. A., & Liao, J. K. (2009) · Science Signaling · doi:10.1126/scisignal.2000143 · Cited by 177
Holstege, H., Pfeiffer, W., Sie, D., Hulsman, M., Nicholas, T. J., Lee, C. C., Ross, T., Lin, J., Miller, M. A., Ylstra, B., et al. (2014) · Genome Research · doi:10.1101/gr.162131.113 · Cited by 152 · cited 2×
“Human life span is genetically finite, as suggested from a recent study and thus unlikely to be ever expanded (Holstege et al., 2014) and appears to be limited to around 130 years (Payne, 2014). of disease, Life Sci (2014), http://dx.doi.org/10.1016/j.lfs.2014.09.009 Practicing health awareness:…”
BackgroundInfluentialMechanisms of cardiovascular disease in accelerated aging syndromes
Capell, B. C., Collins, F. S., & Nabel, E. G. (2007) · Circulation Research · doi:10.1161/circresaha.107.153692 · Cited by 134 · cited 1×
“…accelerated aging, abnormal endothelium-dependent vascular function, accelerated atherogenesis, and die within the first three decades of life mostly from clinical complications of vascular disease such as myocardial infarction and stroke (Capell et al., 2007; Merideth et al., 2008; Nabel, 2012).”
BackgroundNunan, D., Mahtani, K. R., Roberts, N., & Heneghan, C. (2013) · Systematic Reviews · doi:10.1186/2046-4053-2-56 · Cited by 109
Cited by
Oral inflammation and infection, and chronic medical diseases: implications for the elderly
Scannapieco, F. A., & Cantos, A. (2016) · Periodontology 2000 · doi:10.1111/prd.12129 · Cited by 351
Vascular biology of ageing—Implications in hypertension
Harvey, A., Montezano, A. C., & Touyz, R. M. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.04.011 · Cited by 330
“Clinical and experimental studies demonstrate that many prohypertensive systems influence processes of vascular ageing, including aldosterone, ET-1 and growth factors [120–124].”
BackgroundMolecular mechanism involved in cyclophosphamide-induced cardiotoxicity: Old drug with a new vision
Iqubal, A., Iqubal, M. K., Sharma, S., Ansari, M. A., Najmi, A. K., Ali, S. M., Ali, J., & Haque, S. E. (2019) · Life Sciences · doi:10.1016/j.lfs.2018.12.018 · Cited by 328
Endothelin: 30 Years From Discovery to Therapy
Barton, M., & Yanagisawa, M. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12105 · Cited by 295
Self-citationMolecular mechanisms of renal aging
Schmitt, R., & Melk, A. (2017) · Kidney International · doi:10.1016/j.kint.2017.02.036 · Cited by 235
Metadata
- Authors
- Barton, M.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2014-11
- Volume
- 118
- Issue
- 2
- Pages
- 97-109
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W2011113398
- Cited by
- 58
- References
- 25
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.